WelcomeUser Guide
ToSPrivacyCanary
DonateBugsLicense

©2025 Poal.co

508

Archive: https://archive.today/IDoGQ

From the post:

>A woman treated with a pioneering type of immunotherapy for a solid tumour has been in remission for more than 18 years with no further treatments, experts have revealed. The therapy involves taking T-cells, a type of white blood cell, from a patient and genetically engineering them to target and kill cancer cells. These modified T-cells are grown in a laboratory and then infused back into the patient.

Archive: https://archive.today/IDoGQ From the post: >>A woman treated with a pioneering type of immunotherapy for a solid tumour has been in remission for more than 18 years with no further treatments, experts have revealed. The therapy involves taking T-cells, a type of white blood cell, from a patient and genetically engineering them to target and kill cancer cells. These modified T-cells are grown in a laboratory and then infused back into the patient.

(post is archived)

[–] 1 pt

Good news. But remember pharma’s view- one cured patient is one less customer